NORCROSS, GA, June 03, 2013 (Press-News.org) If you are already a Team Pest USA customer, you know how wonderful and enjoyable a pest-free home can be for your entire family. Now this leading Roswell pest control company wants you to pay $100 less for their services while continuing to enjoy a pest-free environment. Simply refer someone you know, and if they sign up for any service offered by Team Pest USA, the company will give you $100 credit for their Roswell pest control or a $25 Visa gift card. It's their way of thanking you for spreading the good word about their great services.
Team Pest USA is also a leading Roswell wildlife removal company. They have wildlife specialists who will come to your home and take care of your wildlife problem humanely. For a termite infestation or any kind of commercial pest control in Roswell, trust Team Pest USA to solve your pest problems for you - promptly, courteously and professionally.
Brandon Pelfrey, Owner of Team Pest USA, was asked about his business philosophy and this is what he said: "We know this business inside out. We provide long-term solutions to your pest problems and help keep your family safe and healthy. That's really why we do it. We're part of this community. We're proud to keep it pest-free."
Team Pest USA has been a leading Roswell pest control company for many years. Trust them to provide you with a thorough and reliable pest control service for your home or business in the safest and most economical way possible.
Visit http://www.pestusa.com/ to learn more about Roswell termite control and wildlife removal.
About Team Pest USA:
Family owned and operated locally, Team Pest USA has been Atlanta's leading pest control experts since 1971. Their commitment to providing industry-leading treatment methods and excellent customer service has gained them many loyal clients across their 40 years in the Atlanta pest control industry. Team Pest USA also offers wildlife removal and relocation in addition to pest control services.
For more information, visit http://www.pestusa.com/
For all media inquiries, please contact:
Allie Petit
Content Manager
Cardinal Web Solutions
http://www.CardinalWebSolutions.com
Refer a Customer to Team Pest USA, Get $100 Credit or $25 Visa Gift Card for Roswell Pest Control
Roswell wildlife removal and pest control company, Team Pest USA, has a great deal for any customer referral.
2013-06-03
ELSE PRESS RELEASES FROM THIS DATE:
Atlanta Video Pros, Optimum Productions, Suggest Connecting with Customers via Interactive Videos
2013-06-03
The Atlanta video production firm, Optimum Productions, wants to remind business owners of the benefits of video advertising. Television and Internet videos are the best ways to consistently attract new clients; they are a cost-effective alternative to traditional print methods such as using a billboard. They have proven to be particularly useful for companies who have an online presence.
The Atlanta video business notes that the return on investment (ROI) is just one reason why using video is the way to go these days. They also point out that more people have become ...
Silver & Black Series Alumni Expected to Make a Presence at MLB's First-Year Player Draft as 2014s and 2015s Showcase their Talent Live June 9th & 10th
2013-06-03
The 10th annual Silver & Black Series presented by the Chicago Scouts Association will take off on June 9th at Symonds/Puckett Field, Triton College in River Grove, Illinois. This year the underclassmen (2015s) will workout first on Sunday with the 2014 graduates taking the field on Monday. In September, Hampshire High School will host the Silver & Black Series with the 2016s working out on September 15th and the 2017s on September 22nd.
Player registration begins on Sunday, June 9 and Monday, June 10 at 8 AM with an expected first pitch beginning at 10 AM. ...
"Worst Ever" Slam by Yahoo! Boosts Sales of New ThiPad Tablet Stand
2013-06-03
In their May 17th "Digital Crave" shopping blog, Yahoo! included the new ThiPad thigh-mounted tablet stand in a piece titled "The Worst iPad Accessories--Ever."
"And they did us a favor," says Jerry McTigue, creator of the ThiPad. "Because the hundreds of readers who went to the ThiPad.com website to see just how bad a product it was, actually discovered how good it was. And they started buying it."
McTigue believes that if the ThiPad can gain converts with horrible publicity like that, there's no telling what it would do if ...
Some patients with treatment-resistant colorectal cancers may have a new option
2013-06-02
PHILADELPHIA — A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research. Preliminary data published in this study showed human tumors with MET amplification, grown in mice, responded to MET inhibitor drugs.
The MET gene is known to be amplified in about ...
Addition of bevacizumab to initial treatment for brain tumors does not extend patients' lives
2013-06-02
Results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) determined that adding bevacizumab to initial treatment for glioblastoma (GBM) did not improve patient overall survival or progression-free survival,. Results were reported June 2 during the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting.
Chicago, Illinois—GBM is the most common primary malignant brain tumor in adults and, despite treatment advances in recent years, the average survival of patients enrolled in clinical trials is ...
New cancer drug shows promise for treating advanced melanoma
2013-06-02
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.
The results were presented at the 2013 meeting of the American Society of Clinical Oncology today in Chicago by Dr. Antoni Ribas, professor of medicine in the UCLA division of hematology-oncology, who led the research. Following Ribas' presentation, the study was published online ahead of press in the New England Journal of Medicine. ...
Test helps target glioblastoma patients most likely to benefit from bevacizumab
2013-06-02
CHICAGO, IL – A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin®), according to new research from The University of Texas MD Anderson Cancer Center.
The results of the study were presented today at the annual meeting of the American Society of Clinical Oncology.
This study is associated with RTOG 0825, a large multi-center Phase III trial that evaluated the addition of bevacizumab to standard chemoradiation and maintenance temozolomide in treating newly diagnosed glioblastoma. Half of the participants ...
Combination of drugs produces dramatic tumor responses in advanced melanoma patients
2013-06-02
CHICAGO, JUNE 2, 2013 — The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Several patients experienced tumor shrinkage of more than 80 percent within ...
Bevacizumab offers no benefit for newly diagnosed glioblastoma, M.D. Anderson-led study finds
2013-06-02
Chicago, IL – The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
The study was presented today on the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting by Mark Gilbert, M.D., professor in MD Anderson's Department of Neuro-Oncology.
Glioblastoma is both the most common and lethal form of brain ...
US oncologists report high career satisfaction, yet many suffer symptoms of burnout
2013-06-02
CHICAGO -- Even though a majority of U.S. oncologists report satisfaction with their careers, many say they have experienced at least one symptom of burnout, a Mayo Clinic-led study has found. The study was released during the American Society of Clinical Oncology's annual meeting in Chicago.
"Oncology can be a tremendously rewarding area of medicine, but caring for patients with cancer is also demanding and stressful," says lead author Tait Shanafelt, M.D., a Mayo Clinic hematologist/oncologist. "Oncologists work long hours, supervise the administration of highly toxic ...
LAST 30 PRESS RELEASES:
Researchers reveal key differences in STING inhibition between humans and mice
Researchers generate lung cells from mouse fibroblasts in just 7 to 10 days
Prizewinner’s research reveals how immune responses to friendly skin microbiota could pave way for novel vaccination responses
Old aerial photos give scientists a new tool to predict sea level rise
20 million for courageous research at ISTA
Ships trigger high and unexpected emissions of the greenhouse gas methane
Optimizing laser irradiation: An in-silico meta-analysis of skin discoloration treatment
Climate crisis could force wild vanilla plants and pollinating insects apart, threatening global supply
Teens report spending 21% of each driving trip looking at their phone
Study explores the ‘social norms’ of distracted driving among teens
Diver-operated microscope brings hidden coral biology into focus
Enhancing the “feel-good” factor of urban vegetation using AI and street view images
A single genetic mutation may have made humans more vulnerable to cancer than chimpanzees
Innovative nanocomposite hydrogel shows promise for cartilage regeneration in osteoarthritis treatment
2025 Guangci Laboratory Medicine Innovation and Development Conference
LabMed Discovery is included in the ICI World Journals database
LabMed Discovery is included in the China Open Access Journal (COAJ) database
Vaccination support program reduces pneumonia-related mortality by 25 percent among the elderly
Over decades, a healthy lifestyle outperforms metformin in preventing onset of Type 2 diabetes
Mental health disorders, malaria, and heart disease most affected by covid pandemic
Green transition will boost UK productivity
Billions voted in 2024, but major new report exposes cracks in global democracy
Researchers find “forever chemicals” impact the developing male brain
Quantum leap in precision sensing across technologies
Upgrading biocrude oil into sustainable aviation fuel using zeolite-supported iron-molybdenum carbide nanocatalysts
For effective science communication, ‘just the facts’ isn’t good enough
RT-EZ: A golden gate assembly toolkit for streamlined genetic engineering of rhodotorula toruloides
Stem Cell Reports announces five new early career editors
Support networks may be the missing link for college students who seek help for excessive drinking
The New England Journal of Medicine shines spotlight on forensic pathology
[Press-News.org] Refer a Customer to Team Pest USA, Get $100 Credit or $25 Visa Gift Card for Roswell Pest ControlRoswell wildlife removal and pest control company, Team Pest USA, has a great deal for any customer referral.